Diabetes Care, Vol 18, Issue 12 1566-1570, Copyright © 1995 by American Diabetes Association

ARTICLES

Morbidity and mortality in the Wolfram syndrome

BT Kinsley, M Swift, RH Dumont and RG Swift
Joslin Diabetes Center, New England Deaconess Hospital, and Harvard Medical School, Boston, Massachusetts, USA.

OBJECTIVE: To determine the major causes of morbidity and mortality in the autosomal recessive Wolfram syndrome, which is defined by diabetes and bilateral progressive optic atrophy with onset in childhood or adolescence. RESEARCH DESIGN AND METHODS: We abstracted and reviewed the medical records of 68 confirmed cases of Wolfram syndrome identified through a nationwide survey of endocrinologists, ophthalmologists, institutes, and homes for the blind. We also reviewed all available autopsy records. RESULTS: The most common causes of morbidity and mortality were the neurological manifestations of this syndrome and the complications of urinary tract atony. There was a lower frequency of diabetic ketoacidosis, no histologically proven diabetic glomerulosclerosis, and less severe, more slowly progressive, diabetic retinopathy than in classic type I diabetic patients. Mortality in Wolfram syndrome is much higher than in type I diabetes; 60% of Wolfram syndrome patients die by age 35. Recognition of these clinical differences from classic type I diabetes is important for the proper management of Wolfram syndrome patients. CONCLUSIONS: Identification of Wolfram syndrome patients among all diabetic patients presenting in childhood or adolescence is important because the management of patients with this syndrome is different from that of patients with classic type I diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Cano, L. Molines, R. Valero, G. Simonin, V. Paquis-Flucklinger, B. Vialettes, and the French Group of Wolfram Syndrome Microvascular Diabetes Complications in Wolfram Syndrome (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness [DIDMOAD]): An age- and duration-matched comparison with common type 1 diabetes Diabetes Care, September 1, 2007; 30(9): 2327 - 2330. [Abstract] [Full Text] [PDF]

				K. Ueda, J. Kawano, K. Takeda, T. Yujiri, K. Tanabe, T. Anno, M. Akiyama, J. Nozaki, T. Yoshinaga, A. Koizumi, et al. Endoplasmic reticulum stress induces Wfs1 gene expression in pancreatic {beta}-cells via transcriptional activation Eur. J. Endocrinol., July 1, 2005; 153(1): 167 - 176. [Abstract] [Full Text] [PDF]

				R. Medlej, J. Wasson, P. Baz, S. Azar, I. Salti, J. Loiselet, A. Permutt, and G. Halaby Diabetes Mellitus and Optic Atrophy: A Study of Wolfram Syndrome in the Lebanese Population J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1656 - 1661. [Abstract] [Full Text] [PDF]

				S. Hofmann, C. Philbrook, K.-D. Gerbitz, and M. F. Bauer Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product Hum. Mol. Genet., August 15, 2003; 12(16): 2003 - 2012. [Abstract] [Full Text] [PDF]

				J. A.L. Minton, A. T. Hattersley, K. Owen, M. I. McCarthy, M. Walker, F. Latif, T. Barrett, and T. M. Frayling Association Studies of Genetic Variation in the WFS1 Gene and Type 2 Diabetes in U.K. Populations Diabetes, April 1, 2002; 51(4): 1287 - 1290. [Abstract] [Full Text] [PDF]

				M. Fukui, Y. Kitagawa, N. Nakamura, and T. Yoshikawa Adult-Onset Type 1 Diabetes With DIDMOAD Syndrome-like Manifestations Arch Intern Med, March 12, 2001; 161(5): 767 - 768. [Full Text] [PDF]

				B. A. Th. F. Gabreëls, D. F. Swaab, D. P. V. de Kleijn, A. Dean, N. G. Seidah, J.-W. Van de Loo, W. J. M. Van de Ven, G. J. M. Martens, and F. W. van Leeuwen The Vasopressin Precursor Is Not Processed in the Hypothalamus of Wolfram Syndrome Patients with Diabetes Insipidus: Evidence for the Involvement of PC2 and 7B2 J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4026 - 4033. [Abstract] [Full Text]